These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9730075)

  • 21. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends of outpatient prescription drug utilization in US children, 2002-2010.
    Chai G; Governale L; McMahon AW; Trinidad JP; Staffa J; Murphy D
    Pediatrics; 2012 Jul; 130(1):23-31. PubMed ID: 22711728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
    Chen CY; Yeh HH; Fang SY; Wu EC; Chang IS; Lin KM
    Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased methylphenidate usage for attention deficit disorder in the 1990s.
    Safer DJ; Zito JM; Fine EM
    Pediatrics; 1996 Dec; 98(6 Pt 1):1084-8. PubMed ID: 8951257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National Ambulatory Medical Care Survey: 2006 summary.
    Cherry DK; Hing E; Woodwell DA; Rechtsteiner EA
    Natl Health Stat Report; 2008 Aug; (3):1-39. PubMed ID: 18972720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tricyclic antidepressants in the treatment of children with attention deficit disorder.
    Pliszka SR
    J Am Acad Child Adolesc Psychiatry; 1987 Mar; 26(2):127-32. PubMed ID: 3584008
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care.
    Martin A; Van Hoof T; Stubbe D; Sherwin T; Scahill L
    Psychiatr Serv; 2003 Jan; 54(1):72-7. PubMed ID: 12509670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rising prevalence of antidepressants among US youths.
    Zito JM; Safer DJ; DosReis S; Gardner JF; Soeken K; Boles M; Lynch F
    Pediatrics; 2002 May; 109(5):721-7. PubMed ID: 11986427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
    Steinhausen HC; Bisgaard C
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
    Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
    J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychotropic practice patterns for youth: a 10-year perspective.
    Zito JM; Safer DJ; DosReis S; Gardner JF; Magder L; Soeken K; Boles M; Lynch F; Riddle MA
    Arch Pediatr Adolesc Med; 2003 Jan; 157(1):17-25. PubMed ID: 12517190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National Ambulatory Medical Care Survey: 2001 summary.
    Cherry DK; Burt CW; Woodwell DA
    Adv Data; 2003 Aug; (337):1-44. PubMed ID: 12924075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of methylphenidate among children in Iceland 1989-2006].
    Zoëga H; Baldursson G; Halldórsson M
    Laeknabladid; 2007 Dec; 93(12):825-32. PubMed ID: 18057472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychotropic drug therapy in children and adolescents.
    Wiener JM
    Psychosomatics; 1982 May; 23(5):488-91, 494-5. PubMed ID: 6125987
    [No Abstract]   [Full Text] [Related]  

  • 36. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program.
    Lawson KA; Johnsrud M; Hodgkins P; Sasané R; Crismon ML
    Clin Ther; 2012 Apr; 34(4):944-956.e4. PubMed ID: 22444786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Attention deficit/hyperactivity disorder].
    Kanbayashi Y
    Ryoikibetsu Shokogun Shirizu; 2003; (40):5-9. PubMed ID: 14626051
    [No Abstract]   [Full Text] [Related]  

  • 38. Psychotherapeutic medication prevalence in Medicaid-insured preschoolers.
    Zito JM; Safer DJ; Valluri S; Gardner JF; Korelitz JJ; Mattison DR
    J Child Adolesc Psychopharmacol; 2007 Apr; 17(2):195-203. PubMed ID: 17489714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating geographic variation in use of psychotropic medications among youth in child welfare.
    Leslie LK; Raghavan R; Hurley M; Zhang J; Landsverk J; Aarons G
    Child Abuse Negl; 2011 May; 35(5):333-42. PubMed ID: 21620160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.
    Gross MD
    Pediatrics; 1976 Sep; 58(3):423-31. PubMed ID: 958770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.